Precigen (PGEN) Cash from Investing Activities (2012 - 2026)

Precigen (PGEN) reported Cash from Investing Activities of $21.0 million for Q1 2026, up 424.72% year-over-year from $4.0 million in Q1 2025, and down 47.41% quarter-over-quarter from $39.9 million in Q4 2025.

Precigen (PGEN) Cash from Investing Activities (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Cash from Investing Activities data on file, last reported at $21.0 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $21.0 million, up 424.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.9 million (up 150.55% YoY), and the FY2025 annual result was -$1.5 million, up 92.59% from the prior year.
  • Cash from Investing Activities eased to $21.0 million in Q1 2026 per PGEN's latest filing, from $39.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $181.9 million in Q3 2022 and troughed at -$65.4 million in Q4 2024.
  • A 5-year average of $13.1 million and a median of $15.0 million in 2024 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities jumped 726.13% in 2022, then slumped 1221.28% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $11.4 million in 2022, then advanced by 16.39% to $13.3 million in 2023, then tumbled by 591.74% to -$65.4 million in 2024, then jumped by 160.99% to $39.9 million in 2025, then sank by 47.41% to $21.0 million in 2026.
  • Business Quant data shows PGEN's Cash from Investing Activities at $21.0 million in Q1 2026, $39.9 million in Q4 2025, and -$63.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -2.89 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -431.90 Mn
9 Abivax 95.45 Bn 95.45 Bn - 579,519.10
10 Precigen 1.32 Bn 1.32 Bn 20.69 Mn 20.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 20.97 Mn
Mar 31, 2026 20.97 Mn
Dec 31, 2025 39.87 Mn
Dec 31, 2025 39.87 Mn
Sep 30, 2025 -63.39 Mn
Sep 30, 2025 -63.39 Mn
Jun 30, 2025 28.44 Mn
Jun 30, 2025 28.44 Mn
Mar 31, 2025 -6.46 Mn
Mar 31, 2025 -6.46 Mn
Dec 31, 2024 -65.37 Mn
Dec 31, 2024 -65.37 Mn
Sep 30, 2024 5.65 Mn
Sep 30, 2024 5.65 Mn
Jun 30, 2024 14.96 Mn
Jun 30, 2024 14.96 Mn
Mar 31, 2024 24.05 Mn
Mar 31, 2024 24.05 Mn
Dec 31, 2023 13.29 Mn
Dec 31, 2023 13.29 Mn